ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin receptor blockers) are equally recommended as first-line treatment for cardiovascular and renal protection in clinical practice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback